| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/08/2023 | 249.65% | Needham | → $5 | Reiterates | Buy → Buy |
| 08/23/2023 | 249.65% | Needham | → $5 | Reiterates | Buy → Buy |
| 06/06/2023 | 249.65% | Needham | → $5 | Reiterates | Buy → Buy |
| 05/26/2023 | 249.65% | Needham | → $5 | Reiterates | Buy → Buy |
| 04/21/2023 | 249.65% | Needham | → $5 | Reiterates | → Buy |
| 03/30/2023 | 249.65% | Needham | → $5 | Reiterates | → Buy |
| 11/10/2022 | 179.72% | SVB Leerink | $8 → $4 | Maintains | Outperform |
| 08/12/2022 | 179.72% | Cantor Fitzgerald | → $4 | Initiates Coverage On | → Overweight |
| 06/06/2022 | 249.65% | Needham | $10 → $5 | Maintains | Buy |
| 05/05/2021 | 599.3% | BTIG | → $10 | Initiates Coverage On | → Buy |
| 04/05/2021 | 599.3% | Needham | → $10 | Initiates Coverage On | → Buy |
What is the target price for Mereo BioPharma Group (MREO)?
The latest price target for Mereo BioPharma Group (NASDAQ: MREO) was reported by Needham on September 8, 2023. The analyst firm set a price target for $5.00 expecting MREO to rise to within 12 months (a possible 249.65% upside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Mereo BioPharma Group (MREO)?
The latest analyst rating for Mereo BioPharma Group (NASDAQ: MREO) was provided by Needham, and Mereo BioPharma Group reiterated their buy rating.
When is the next analyst rating going to be posted or updated for Mereo BioPharma Group (MREO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Mereo BioPharma Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Mereo BioPharma Group was filed on September 8, 2023 so you should expect the next rating to be made available sometime around September 8, 2024.
Is the Analyst Rating Mereo BioPharma Group (MREO) correct?
While ratings are subjective and will change, the latest Mereo BioPharma Group (MREO) rating was a reiterated with a price target of $0.00 to $5.00. The current price Mereo BioPharma Group (MREO) is trading at is $1.43, which is within the analyst's predicted range.